Nonfatal myocardial infarction is, by itself, an inappropriate end point in clinical trials in cardiology.
Fleiss
J L
JL
Bigger
J T
JT
McDermott
M
M
Miller
J P
JP
Moon
T
T
Moss
A J
AJ
Oakes
D
D
Rolnitzky
L M
LM
Therneau
T M
TM
D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D009203:Myocardial Infarction; D012107:Research Design